Advanced prescription of injectable anticancer drugs: Safety assessment in a European Comprehensive Cancer Centre using the risk matrix approach.

Alexandre Acramel Sandy Blondeel-GomesMathilde DupréOrnella Tangila KayembeAude RochereauLaurence Escalup Romain-Pacôme DesmarisNathalie JourdanAdeline CordaryPauline Vaflard Paul-Henri Cottu Audrey Bellesoeur

Published in: British journal of clinical pharmacology (2024)

Advanced prescription of injectable anticancer drugs appears to be a safe practice for patients when combined with risk management. The major risks identified concerned missed dose adjustment, prescription duplication and lack of consideration for abnormal biology data.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
healthcare
primary care
chronic kidney disease
papillary thyroid
prognostic factors
electronic health record
squamous cell carcinoma
big data
machine learning
patient reported outcomes
squamous cell
quality improvement
human health
deep learning